Z-0154-2019 Class II Terminated

Recalled by Zimmer Biomet, Inc. — Warsaw, IN

FDA device recall Z-0154-2019 was initiated by Zimmer Biomet, Inc. on Aug 8, 2018 and is designated Class II. Reason for recall: There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open. The recall status is terminated (terminated Jul 30, 2020). Affected quantity: 16.

Recall Details

Product Type
Devices
Report Date
Oct 24, 2018
Initiation Date
Aug 8, 2018
Termination Date
Jul 30, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16

Product Description

Affixus Hip Fracture Nail Left 125 13 mm x 260 mm, Item Number 814413260 Product Usage: Intended for the fixation of fractures

Reason for Recall

There were complaints indicating that when the product was opened in surgery, the sterile packaging was already open.

Distribution Pattern

Worldwide Distribution - US Nationwide in the states of: AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WY. The products were distributed to the following foreign countries: Chile, Netherlands.

Code Information

Lot Numbers: 679240

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0154-2019
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.